Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
8.35
+0.23 (2.83%)
At close: Jun 6, 2025, 4:00 PM
8.32
-0.03 (-0.36%)
After-hours: Jun 6, 2025, 4:04 PM EDT
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $293.34 million as of June 6, 2025. Its market cap has decreased by -41.16% in one year.
Market Cap
293.34M
Enterprise Value
-32.18M
1-Year Change
-41.16%
Ranking
Category
Stock Price
$8.35
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $293.34M, an increase of 16.86%. That is a compound annual growth rate of 4.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 293.34M | -52.08% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |